OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Differential Effects of the Mitochondria-Active Tetrapeptide SS-31 (D-Arg-dimethylTyr-Lys-Phe-NH2) and Its Peptidase-Targeted Prodrugs in Experimental Acute Kidney Injury
Jean-Christophe Wyss, Rajesh Kumar, Josip Mikulic, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 16
Jean-Christophe Wyss, Rajesh Kumar, Josip Mikulic, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 16
Showing 16 citing articles:
Oxidative Stress and Ischemia/Reperfusion Injury in Kidney Transplantation: Focus on Ferroptosis, Mitophagy and New Antioxidants
Simona Granata, Valentina Votrico, Federica Spadaccino, et al.
Antioxidants (2022) Vol. 11, Iss. 4, pp. 769-769
Open Access | Times Cited: 86
Simona Granata, Valentina Votrico, Federica Spadaccino, et al.
Antioxidants (2022) Vol. 11, Iss. 4, pp. 769-769
Open Access | Times Cited: 86
Global trends of delayed graft function in kidney transplantation from 2013 to 2023: a bibliometric analysis
Zhiling Yao, Mingqian Kuang, Zhen Li
Renal Failure (2024) Vol. 46, Iss. 1
Open Access | Times Cited: 7
Zhiling Yao, Mingqian Kuang, Zhen Li
Renal Failure (2024) Vol. 46, Iss. 1
Open Access | Times Cited: 7
SS-31, a Mitochondria-Targeting Peptide, Ameliorates Kidney Disease
Yuexin Zhu, Manyu Luo, Xue Bai, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 26
Yuexin Zhu, Manyu Luo, Xue Bai, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 26
The Mitochondrion: A Promising Target for Kidney Disease
Cem Tanrıöver, Sidar Çöpür, Duygu Uçku, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 570-570
Open Access | Times Cited: 14
Cem Tanrıöver, Sidar Çöpür, Duygu Uçku, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 570-570
Open Access | Times Cited: 14
The Other Angiotensin II Receptor: AT2R as a Therapeutic Target
Lucienne Juillerat‐Jeanneret
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 5, pp. 1978-1995
Closed Access | Times Cited: 29
Lucienne Juillerat‐Jeanneret
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 5, pp. 1978-1995
Closed Access | Times Cited: 29
The Mitochondria-targeted Peptide, Bendavia, Attenuated Ischemia/Reperfusion-induced Stroke Damage
Takahiko Imai, Hirofumi Matsubara, Shinsuke Nakamura, et al.
Neuroscience (2020) Vol. 443, pp. 110-119
Closed Access | Times Cited: 27
Takahiko Imai, Hirofumi Matsubara, Shinsuke Nakamura, et al.
Neuroscience (2020) Vol. 443, pp. 110-119
Closed Access | Times Cited: 27
Nano-Technological Approaches for Targeting Kidney Diseases With Focus on Diabetic Nephropathy: Recent Progress, and Future Perspectives
Bo Lin, Ying‐Yu Ma, Wang Jun-wei
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 16
Bo Lin, Ying‐Yu Ma, Wang Jun-wei
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 16
Phloretin as an add-on therapy to losartan attenuates diabetes-induced AKI in rats: A potential therapeutic approach targeting TLR4-induced inflammation
Vishwadeep Shelke, Neha Dagar, Anil Bhanudas Gaikwad
Life Sciences (2023) Vol. 332, pp. 122095-122095
Closed Access | Times Cited: 8
Vishwadeep Shelke, Neha Dagar, Anil Bhanudas Gaikwad
Life Sciences (2023) Vol. 332, pp. 122095-122095
Closed Access | Times Cited: 8
Recent advances in engineered nanomaterials for acute kidney injury theranostics
Lefeng Wang, Yunjing Zhang, Yangyang Li, et al.
Nano Research (2020) Vol. 14, Iss. 4, pp. 920-933
Closed Access | Times Cited: 23
Lefeng Wang, Yunjing Zhang, Yangyang Li, et al.
Nano Research (2020) Vol. 14, Iss. 4, pp. 920-933
Closed Access | Times Cited: 23
Nanomedicine in the Treatment of Diabetic Nephropathy
Nimeet Desai, HariPriya Koppisetti, Shreya Pande, et al.
Future Medicinal Chemistry (2021) Vol. 13, Iss. 7, pp. 663-686
Closed Access | Times Cited: 14
Nimeet Desai, HariPriya Koppisetti, Shreya Pande, et al.
Future Medicinal Chemistry (2021) Vol. 13, Iss. 7, pp. 663-686
Closed Access | Times Cited: 14
Elamipretide treatment during pregnancy ameliorates the progression of polycystic kidney disease in maternal and neonatal mice with PKD1 mutations
Nastaran Daneshgar, Peir‐In Liang, Renny S. Lan, et al.
Kidney International (2021) Vol. 101, Iss. 5, pp. 906-911
Open Access | Times Cited: 9
Nastaran Daneshgar, Peir‐In Liang, Renny S. Lan, et al.
Kidney International (2021) Vol. 101, Iss. 5, pp. 906-911
Open Access | Times Cited: 9
Promising Therapeutic Strategies Targeting Mitochondria in Kidney Diseases: From Small Molecules to Whole Mitochondria
Alexis Paulina Jiménez‐Uribe, José Pedraza-Chaverrı́
Future Pharmacology (2022) Vol. 2, Iss. 3, pp. 256-275
Open Access | Times Cited: 4
Alexis Paulina Jiménez‐Uribe, José Pedraza-Chaverrı́
Future Pharmacology (2022) Vol. 2, Iss. 3, pp. 256-275
Open Access | Times Cited: 4
SS31 Ameliorates Oxidative Stress via the Restoration of Autophagic Flux to Protect Aged Mice From Hind Limb Ischemia
Qiaoyun Yang, Chunqiu Li, Qingwei Chen
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 3
Qiaoyun Yang, Chunqiu Li, Qingwei Chen
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 3
SS-31 protects diabetic nephropathy progression: A systematic review of in vivo and in vitro studies
Jonathan Christianto Sutadji, Dian Anggraini Permatasari Musalim, David Setyo Budi, et al.
Journal of Pharmacy & Pharmacognosy Research (2024) Vol. 12, Iss. 5, pp. 956-971
Open Access
Jonathan Christianto Sutadji, Dian Anggraini Permatasari Musalim, David Setyo Budi, et al.
Journal of Pharmacy & Pharmacognosy Research (2024) Vol. 12, Iss. 5, pp. 956-971
Open Access
Mitochondria-Targeted Antioxidants and Cancer
Sanjay Bharati, Sachin Shetty
Springer eBooks (2021), pp. 1-22
Closed Access | Times Cited: 1
Sanjay Bharati, Sachin Shetty
Springer eBooks (2021), pp. 1-22
Closed Access | Times Cited: 1
Mitochondrial dysfunction in kidney diseases
Daniel L. Galvan, Luca Perico
Clinical bioenergetics (2020), pp. 119-154
Closed Access
Daniel L. Galvan, Luca Perico
Clinical bioenergetics (2020), pp. 119-154
Closed Access
